Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans.
about
Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's diseaseAlzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studiesAge-Related Cognitive Impairment as a Sign of Geriatric Neurocardiovascular Interactions: May Polyphenols Play a Protective Role?Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brainCardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic strokeGliovascular disruption and cognitive deficits in a mouse model with features of small vessel disease.Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia.Cocoa and Dark Chocolate Polyphenols: From Biology to Clinical Applications.Is apolipoprotein E4 an important risk factor for vascular dementia?Long-term blood pressure variability throughout young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study.MRI features of Binswanger's disease predict prognosis and associated pathologyStatin use and cognitive function: population-based observational study with long-term follow-upTherapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice.Neurovascular and neurometabolic derailment in aging and Alzheimer's disease.Medial temporal lobe atrophy, white matter hyperintensities and cognitive impairment among Nigerian African stroke survivors.Role of neuroimaging in multidisciplinary approach towards Non-Alzheimer's dementia.Nocturnal Blood Pressure in Young Adults and Cognitive Function in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.Corpora Amylacea in Neurodegenerative Diseases: Cause or Effect?In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRIGender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease.Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.Visit-to-Visit Variability in Blood Pressure Is Related to Late-Life Cognitive Decline.The association between SBP and mortality risk differs with level of cognitive function in very old individualsRole of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics.Impaired cerebrovascular hemodynamics are associated with cerebral white matter damage.Cerebral Small Vessel Disease and Motoric Cognitive Risk Syndrome: Results from the Kerala-Einstein StudyCerebrovascular contributions to Alzheimer's disease pathophysiology and potential therapeutic interventions in mouse models.A major role for cardiovascular burden in age-related cognitive decline.Dementia risk and prevention by targeting modifiable vascular risk factors.Vascular Cognitive Impairment through the Looking Glass of Transcranial Magnetic Stimulation.The impact of cerebrovascular aging on vascular cognitive impairment and dementia.Principles of precision medicine in stroke.The microcirculation: a key player in obesity-associated cardiovascular disease.Declines and Impairment in Executive Function Predict Onset of Physical Frailty.Day-to-Day Blood Pressure Variability and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study.Association of Cerebral Microbleeds With Cognitive Decline and Dementia.Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors.The Association between Cerebral White Matter Lesions and Plasma Omega-3 to Omega-6 Polyunsaturated Fatty Acids Ratio to Cognitive Impairment Development.First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia.
P2860
Q26750515-07ADB7F9-D06E-4470-8BA2-C4614E678802Q26798325-7F21C3A7-E1D0-4DA5-AA32-24B2ACE54909Q26800943-0EC10654-CE36-4E7C-918E-046AF4C4C423Q26824027-883E1EFB-9A61-4317-92E8-2A20A09B9EAAQ26824825-F4B66CBE-4ADA-4AAE-9051-DB5514832571Q30891190-8E6B381E-84EA-4D51-B424-5D2D8FF1B4CEQ33624463-CE63B4AD-AA20-4C21-B4E5-BD6CF2AE8E86Q33780610-97777702-DA9C-4D0D-9086-22E9FE608F6AQ34028845-F4A568EE-957D-4405-B824-4335EF7336C2Q34315767-39C0DBDB-6F48-4D08-AEB3-2137EA01325FQ34562869-9E46A2F5-0954-4921-B8C3-4C78B656644DQ34776124-C2B279F1-1A90-4F49-AD5A-0CEDFE1D6654Q35572970-E0DD3B7F-0F2A-46B7-8A2B-E6768EE68D05Q35651255-F57611EF-E1FA-4E7E-9908-A9624FF18FA6Q35828008-22F344CC-F3C7-4323-8116-CEBD22395AB1Q36059072-A6A044BF-26F9-45ED-AF89-129BE857A175Q36087150-CC6A872F-1483-404F-B47E-959F01318045Q36252820-428DE6CA-EEF9-4799-BE6D-9C911F20B9E8Q36655420-0ED4815B-6BF4-4CFA-8640-5B946017B3B8Q36694586-6C6BE7E0-95B5-498B-A1CE-0847E841D9DAQ36767965-1F944BDC-A618-4024-B67B-37FE292A5396Q36786388-FAAEC158-E14B-47B7-80F0-C1BB237DD68AQ36989402-68D6FECD-2AE8-4807-B888-E21DAC9B2F48Q37100321-D925FAA3-78BF-4515-8168-9C81AC388CF6Q37476530-C831AA56-34FF-4A60-A4E0-46C89F22D341Q37559287-5135BD59-6013-4DC8-A732-C7BABBBED136Q37626022-BB247F47-CB41-4246-922E-FC0A8118575BQ38114940-2B7643D0-6494-415B-8BA6-B1C7D5308967Q38316448-3B5B7985-27C3-462D-AE34-B98BACFBD9AEQ38653373-EBF840AF-FB5C-4925-863F-BC5BFD23F2EEQ38738864-370FA946-7D9F-476C-BF84-356024D0EC94Q38969718-A9D4E3B5-F95A-403C-9160-610E6A29A82EQ39029591-8774CFE7-175E-4117-94A9-FEA8866D9EC8Q39290927-C4C272F9-3C3C-4FB2-B3F5-5EFD891D1637Q39846830-2035D6AC-D43B-4DC5-8BD4-D4395145EE40Q40091662-960CD92F-67AB-4123-948C-E43A7DF9D123Q40714238-9A0C4D76-ECBA-415E-949F-9E10C4E79A6AQ41199801-2D6ECF68-9ADD-4315-B8DF-30B252EEA296Q41878211-D3DA9CB1-A8FC-4390-A218-08667C613E01Q42568045-69DDBC5C-8BA3-43FF-B2E9-22565C317557
P2860
Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cerebrovascular disease and me ...... athological studies in humans.
@en
type
label
Cerebrovascular disease and me ...... athological studies in humans.
@en
prefLabel
Cerebrovascular disease and me ...... athological studies in humans.
@en
P1433
P1476
Cerebrovascular disease and me ...... athological studies in humans.
@en
P2093
Raj N Kalaria
P304
P356
10.1161/STROKEAHA.112.655803
P407
P577
2012-08-09T00:00:00Z